Tech Company M&A Transactions
Promedior Acquisition
Headquartered in Lexington, Promedior was bought by Roche. The parties disclosed the acquisition price to be $1.4 billion.
Transaction Overview
Company Name
Acquired By
Announced On
11/15/2019
Transaction Type
M&A
Amount
$1,390,000,000
M&A Terms
Under the terms of the merger agreement, Roche will make an upfront cash payment of USD 390 million, plus additional contingent payments of up to USD 1 billion based on the achievement of certain predetermined development, regulatory and commercial milestones.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
101 Hartwell Ave.
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Overview
Promedior is a product-focused biopharmaceutical company developing novel therapeutics for the treatment of fibrotic disorders and diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Russell Ellison
Chief Medical Officer
Bernt Blink
Chief Medical Officer
Renu Gupta
Chief Operating Officer
Richard Jack
VP - Bus. Development
Scott Willett
Browse more venture capital transactions:
Prev: 11/15/2019: Postprocess Technologies venture capital transaction
Next: 11/15/2019: DadeSystems venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs